Apsen Farmaceutica S.a.
Clinical trials sponsored by Apsen Farmaceutica S.a., explained in plain language.
-
Can a common Motion-Sickness drug tame vertigo as well as the standard?
Symptom relief CompletedThis trial tests whether meclizine, a drug often used for motion sickness, works as well as dimenhydrinate for controlling acute vertigo symptoms that come from inner-ear problems. Adults aged 18 to 64 with moderate to severe vertigo take one of the two drugs three times a day fo…
Phase 3 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Can a purified form of ibuprofen better tame osteoarthritis pain?
Symptom relief CompletedThis trial tests whether S(+) ibuprofen, a purified form of the common painkiller, can reduce pain in people with knee or hip osteoarthritis better than a standard ibuprofen product. Researchers will compare the two treatments in about 176 adults aged 18 to 75. Participants will …
Phase 2 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Can a new form of ibuprofen beat standard pain relief for back pain?
Symptom relief CompletedThis phase II trial tests whether S(+) ibuprofen, a modified form of the common painkiller, provides better pain relief than a standard treatment for people with sudden, at least moderate low back pain. Researchers will compare the two approaches in 177 adults whose pain started …
Phase 2 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Can a new drug beat standard painkillers for Post-Dental surgery pain?
Symptom relief CompletedThis phase 3 trial enrolls adults aged 18 to 40 who need an impacted wisdom tooth removed. Researchers compare the experimental drug APSCTC against two established painkillers to see if it provides better relief from post-surgical pain. Participants receive one of the treatments …
Phase 3 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated Sep 06, 2026 00:00 UTC
-
Dexibuprofen put to the test: can a common painkiller pass safety checks?
Knowledge-focused CompletedResearchers are running a Phase 1 trial to check the safety of 200 mg dexibuprofen, a nonsteroidal anti-inflammatory drug, in healthy adults. The study enrolls 52 men and women aged 18 to 50 with a healthy body weight. Participants receive single and multiple oral doses while fas…
Phase 1 • Sponsor: Apsen Farmaceutica S.A. • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC
-
Can a common Painkiller's cousin pass the safety test?
Knowledge-focused CompletedResearchers are running a Phase 1 trial to check how safe a 300 mg dose of dexibuprofen, a pain-relieving drug similar to ibuprofen, is for healthy adults. The study gives the drug once and then repeatedly, both with and without food, to see how the body handles it. Participants …
Phase 1 • Sponsor: Apsen Farmaceutica S.A. • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC